EE05025B1 - Fumaarhappe derivaadid kasutamiseks transplantaadivastase reaktsiooni raviks - Google Patents

Fumaarhappe derivaadid kasutamiseks transplantaadivastase reaktsiooni raviks

Info

Publication number
EE05025B1
EE05025B1 EEP200000654A EEP200000654A EE05025B1 EE 05025 B1 EE05025 B1 EE 05025B1 EE P200000654 A EEP200000654 A EE P200000654A EE P200000654 A EEP200000654 A EE P200000654A EE 05025 B1 EE05025 B1 EE 05025B1
Authority
EE
Estonia
Prior art keywords
fumaric acid
treatment
acid derivatives
graft reaction
combination
Prior art date
Application number
EEP200000654A
Other languages
English (en)
Estonian (et)
Inventor
Kumar Joshi Rajendra
Strebel Hans-Peter
Original Assignee
Fumapharm Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fumapharm Ag filed Critical Fumapharm Ag
Publication of EE200000654A publication Critical patent/EE200000654A/xx
Publication of EE05025B1 publication Critical patent/EE05025B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EEP200000654A 1998-08-31 1999-08-20 Fumaarhappe derivaadid kasutamiseks transplantaadivastase reaktsiooni raviks EE05025B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19839566A DE19839566C2 (de) 1998-08-31 1998-08-31 Verwendung von Fumarsäurederivaten in der Transplantationsmedizin
PCT/EP1999/006110 WO2000012072A2 (fr) 1998-08-31 1999-08-20 Utilisation de derives d'acide fumarique dans la medecine de transplantation

Publications (2)

Publication Number Publication Date
EE200000654A EE200000654A (et) 2002-04-15
EE05025B1 true EE05025B1 (et) 2008-06-16

Family

ID=7879272

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000654A EE05025B1 (et) 1998-08-31 1999-08-20 Fumaarhappe derivaadid kasutamiseks transplantaadivastase reaktsiooni raviks

Country Status (25)

Country Link
US (1) US6359003B1 (fr)
EP (1) EP1107749B1 (fr)
JP (1) JP3553883B2 (fr)
CN (1) CN1195511C (fr)
AT (1) ATE241353T1 (fr)
AU (1) AU746958B2 (fr)
BG (1) BG64435B1 (fr)
BR (1) BR9908722A (fr)
CA (1) CA2322188C (fr)
DE (2) DE19839566C2 (fr)
DK (1) DK1107749T3 (fr)
EE (1) EE05025B1 (fr)
ES (1) ES2195609T3 (fr)
HK (1) HK1040623B (fr)
HU (1) HUP0101854A3 (fr)
IL (1) IL138110A0 (fr)
NO (1) NO20006462L (fr)
NZ (1) NZ506573A (fr)
PL (1) PL198211B1 (fr)
PT (1) PT1107749E (fr)
RS (1) RS49780B (fr)
RU (1) RU2210364C2 (fr)
SK (1) SK286352B6 (fr)
TR (1) TR200002475T2 (fr)
WO (1) WO2000012072A2 (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19853487A1 (de) * 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
US6342294B1 (en) 1999-08-12 2002-01-29 Bruce G. Ruefer Composite PTFE article and method of manufacture
DE10000577A1 (de) * 2000-01-10 2001-07-26 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten
DE10101307A1 (de) * 2001-01-12 2002-08-01 Fumapharm Ag Muri Fumarsäurederivate als NF-kappaB-Inhibitor
AU2002219236B2 (en) * 2001-01-12 2006-02-09 Biogen International Gmbh Fumaric acid amides
DE10217314A1 (de) * 2002-04-18 2003-11-13 Fumapharm Ag Muri Carbocyclische und Oxacarboncyclische Fumarsäure-Oligomere
AU2003236156A1 (en) * 2003-04-24 2005-01-04 Shin-Jen Shiao Pharmaceutical compositions used for immune disease treatment and improvement
DE602004010531T2 (de) * 2003-09-09 2008-07-03 Fumapharm Ag Verwendung von fumarsäure-derivaten zur behandlung von herzinsuffizienz und asthma
DE10360869A1 (de) * 2003-09-09 2005-04-07 Fumapharm Ag Verwendung von Fumarsäurederivaten zur Therapie der Herzinsuffizienz, der Hyperkeratose und von Asthma
PT2316430E (pt) 2004-10-08 2012-06-26 Forward Pharma As Composições farmacêuticas de libertação controlada compreendendo um éster de ácido fumárico
EP1915334A2 (fr) * 2005-07-07 2008-04-30 Aditech Pharma AB Nouveaux sels de monoalkylesters d'acide fumarique et leur utilisation pharmaceutique
ATE455783T1 (de) 2005-07-07 2010-02-15 Aditech Pharma Ag Neue glucopyranoseester und glucofuranoseester von fumarsäurealkylestern und deren pharmazeutische verwendung
JP2009510137A (ja) * 2005-10-07 2009-03-12 アディテック・ファルマ・アクチボラゲット フマル酸エステルを含む制御放出医薬組成物
WO2007042035A2 (fr) * 2005-10-07 2007-04-19 Aditech Pharma Ab Therapie de combinaison pour le traitement d'un trouble auto-immun et/ou inflammatoire et de conditions associees
EP3135282A1 (fr) * 2007-02-08 2017-03-01 Biogen MA Inc. Neuroprotection dans des maladies démyélinisantes
HRP20220902T3 (hr) 2007-02-08 2022-10-14 Biogen Ma Inc. Pripravci i njihova upotreba u liječenju multiple skleroze
WO2009078754A1 (fr) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Système d'administration de médicament permettant d'administrer des substances pharmaceutiquement actives faiblement hydrosolubles
PL2334378T3 (pl) 2008-08-19 2014-09-30 Xenoport Inc Proleki wodorofumaranu metylu, ich kompozycje farmaceutyczne i sposoby zastosowania
UA112975C2 (uk) 2009-01-09 2016-11-25 Форвард Фарма А/С Фармацевтичний склад, що містить в матриці, яка піддається ерозії, один або більше ефірів фумарової кислоти
DK2718257T3 (en) 2011-06-08 2018-02-12 Biogen Ma Inc PROCEDURE FOR THE PREPARATION OF HIGH PURITY Crystalline DIMETHYL FUMARATE
BR112014002407A2 (pt) * 2011-08-30 2017-02-21 Toyama Chemical Co Ltd método para melhorar a terapia contra doenças autoimunes tais como artrite reumatóide
EP2782561A1 (fr) 2011-11-24 2014-10-01 Synthon BV Libération contrôlée de particules comprenant du diméthylfumarate
US9504679B2 (en) 2011-12-19 2016-11-29 Bjoern Colin Kahrs Pharmaceutical compositions comprising glitazones and Nrf2 activators
US20130158077A1 (en) 2011-12-19 2013-06-20 Ares Trading S.A. Pharmaceutical compositions
AU2013203445C1 (en) * 2012-02-07 2017-04-20 Biogen Ma Inc. Pharmaceutical compositions containing dimethyl fumarate
CA2864040A1 (fr) 2012-02-07 2013-08-15 Xenoport, Inc. Composes de fumarate de morpholinoalkyle, compositions pharmaceutiques et procedes d'utilisation
AU2013305684B2 (en) 2012-08-22 2016-11-24 Xenoport, Inc. Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
US10945984B2 (en) 2012-08-22 2021-03-16 Arbor Pharmaceuticals, Llc Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
US20140057918A1 (en) * 2012-08-22 2014-02-27 Xenoport, Inc. Methods of Use for Monomethyl Fumarate and Prodrugs Thereof
CN103483194B (zh) * 2012-11-30 2016-03-09 杨寅柯 一种2-氟代富马酸酯(结构式i)及其制备方法及应用
ES2733961T3 (es) 2012-12-21 2019-12-03 Biogen Ma Inc Derivados de fumarato sustituidos con deuterio
US8669281B1 (en) 2013-03-14 2014-03-11 Alkermes Pharma Ireland Limited Prodrugs of fumarates and their use in treating various diseases
KR101814474B1 (ko) 2013-03-14 2018-01-12 엘커메스 파마 아일랜드 리미티드 푸마레이트의 프로드럭 및 다양한 질환을 치료하는데 있어서의 이들의 용도
US10179118B2 (en) 2013-03-24 2019-01-15 Arbor Pharmaceuticals, Llc Pharmaceutical compositions of dimethyl fumarate
US9302977B2 (en) 2013-06-07 2016-04-05 Xenoport, Inc. Method of making monomethyl fumarate
WO2014205392A1 (fr) 2013-06-21 2014-12-24 Xenoport, Inc. Co-cristaux de diméthyl fumarate
EP3041467A1 (fr) 2013-09-06 2016-07-13 XenoPort, Inc. Formes cristallines de méthyl(2e)but-2-ène-1,4-dioate de (n,n-diéthylcarbamoyl)méthyle, procédés de synthèse et d'utilisation
WO2015127450A1 (fr) 2014-02-24 2015-08-27 Alkermes Pharma Ireland Limited Sulfonamide et promédicaments de fumarates de sulfinamide et leur utilisation dans le traitement de diverses maladies
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters
WO2016061393A1 (fr) 2014-10-15 2016-04-21 Xenoport, Inc. Composés de fumarate, compositions pharmaceutiques et procédés d'utilisation
MX382175B (es) * 2015-02-08 2025-03-13 Alkermes Pharma Ireland Ltd Composiciones de profármaco de monometilfumarato
DK3273951T3 (da) 2015-03-27 2020-11-02 Symbionyx Pharmaceuticals Inc Sammensætninger og fremgangsmåder til behandling af psoriasis
WO2017060400A1 (fr) 2015-10-07 2017-04-13 Neurovive Pharmaceutical Ab Métabolites protégés à base d'acide carboxylique pour le traitement des maladies liées à des dysfonctions mitochondriales
CN106265621B (zh) * 2016-09-19 2019-05-17 苏州大学 富马酸二甲酯在制备预防和治疗移植物抗宿主病及移植物抗白血病药物中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2530372A1 (de) * 1975-07-08 1977-01-13 Walter Dr Schweckendiek Pharmazeutische zubereitungen zur behandlung von psoriasis
DE2621214C3 (de) * 1976-05-13 1981-11-12 Koronis Gmbh Chemisch-Pharmazeutische Praeparate, 5441 Sassen Verwendung von Stabilisatoren in Arzneimitteln mit Fumarsäuremonoäthylester und desen Mineralsalzen
US5149695A (en) * 1985-01-15 1992-09-22 Speiser Peter P Fumaric acid derivatives, process for the production thereof and pharmaceutical compositions containing same
CH664150A5 (de) * 1985-01-15 1988-02-15 Peter Paul Prof Dr Speiser Fumarsaeureprodrug, verfahren zu seiner herstellung und dieses enthaltende darreichungsformen.
US4959389A (en) * 1987-10-19 1990-09-25 Speiser Peter P Pharmaceutical preparation for the treatment of psoriatic arthritis
US5424332A (en) * 1987-10-19 1995-06-13 Speiser; Peter P. Pharmaceutical composition and process for the production thereof
MC1999A1 (fr) * 1987-12-18 1990-01-26 Hoffmann La Roche Composes tricycliques
US6011000A (en) * 1995-03-03 2000-01-04 Perrine; Susan P. Compositions for the treatment of blood disorders
EP2298350A3 (fr) 1996-07-26 2011-06-08 Susan P. Perrine Compositions contenant un agent inducteur ainsi qu'un agent antiviral et destinees au traitement de troubles viraux
WO1998027970A2 (fr) * 1996-12-24 1998-07-02 National Research Council Of Canada Traitement de maladies ou prevention de dommages cellulaires causes par des radicaux libres contenant de l'oxygene
DE19721099C2 (de) * 1997-05-20 1999-12-02 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten
DE19814358C2 (de) * 1998-03-31 2002-01-17 Fumapharm Ag Muri Verwendung von Alkylhydrogenfumaraten zur Behandlung von Psoriasis, psoriatischer Arthritis, Neurodermitis und Enteritis regionalis Crohn

Also Published As

Publication number Publication date
DE19839566A1 (de) 2000-03-09
HUP0101854A3 (en) 2003-04-28
EE200000654A (et) 2002-04-15
DK1107749T3 (da) 2003-08-18
JP3553883B2 (ja) 2004-08-11
PL198211B1 (pl) 2008-06-30
SK286352B6 (en) 2008-07-07
CA2322188A1 (fr) 2000-03-09
WO2000012072A2 (fr) 2000-03-09
BR9908722A (pt) 2001-10-16
AU5737899A (en) 2000-03-21
NO20006462L (no) 2001-04-30
ATE241353T1 (de) 2003-06-15
NO20006462D0 (no) 2000-12-18
HK1040623A1 (en) 2002-06-21
RU2210364C2 (ru) 2003-08-20
AU746958B2 (en) 2002-05-09
TR200002475T2 (tr) 2001-03-21
DE59905763D1 (de) 2003-07-03
CN1316901A (zh) 2001-10-10
BG64435B1 (en) 2005-02-28
ES2195609T3 (es) 2003-12-01
RS49780B (sr) 2008-06-05
BG104679A (en) 2001-02-28
IL138110A0 (en) 2001-10-31
YU58800A (sh) 2002-03-18
CN1195511C (zh) 2005-04-06
DE19839566C2 (de) 2002-01-17
NZ506573A (en) 2002-10-25
HK1040623B (zh) 2005-08-19
HUP0101854A2 (hu) 2001-11-28
SK2572001A3 (en) 2002-05-09
PL347359A1 (en) 2002-04-08
CA2322188C (fr) 2004-03-09
PT1107749E (pt) 2003-08-29
WO2000012072A3 (fr) 2000-05-04
EP1107749A2 (fr) 2001-06-20
EP1107749B1 (fr) 2003-05-28
JP2002525276A (ja) 2002-08-13
US6359003B1 (en) 2002-03-19

Similar Documents

Publication Publication Date Title
EE05025B1 (et) Fumaarhappe derivaadid kasutamiseks transplantaadivastase reaktsiooni raviks
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
DE59905954D1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
TR200102648T2 (tr) Büyümeyi destekleyen bileşimler
YU57599A (sh) Primena derivata fumarne kiseline
ATE181329T1 (de) Substituierte dibenzooxazepin-verbindungen, pharmazeutische zusammensetzungen und verfahren zur verwendung
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
ATE152628T1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
EP1173163A4 (fr) Compositions pharmaceutiques de tetrac et leurs techniques d'utilisation
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
DE60230155D1 (de) Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung
ATE90563T1 (de) Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie.
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
DE69314586D1 (de) Arzneimittelzusammensetzung enthaltend TCF-II
ATE252903T1 (de) Arzneimittel zur behandlung konvulsivischer zustände
UA36167A (uk) Спосіб лікування панкреатиту

Legal Events

Date Code Title Description
HE1A Change of address
KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20090820